Crossmark

Efficacy of a 7-day vonoprazan, sitafloxacin, and amoxicillin triple therapy as a fourth-line salvage regimen for refractory Helicobacter pylori infection

Crossref DOI link: https://doi.org/10.1186/s12876-025-04226-x

Published Online: 2025-09-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Geeratragool, Tanawat

Tansirichaiya, Supathep

Kamolvit, Witchuda

Atthakitmongkol, Thanapat

Leartsiwawinyu, Wasawat

Thaipisuttikul, Iyarit

Chuenprapai, Pritsana

Leelakusolvong, Somchai

Limwong, Chanin

Maneerattanaporn, Monthira
Funding

Funding for this research was provided by:

Mahidol University
License Information

Text and Data Mining valid from 2025-09-26

Version of Record valid from 2025-09-26
More Information

Article History

Received: 20 May 2025

Accepted: 6 August 2025

First Online: 26 September 2025

Declarations

:

: This study was conducted in accordance with the ethical principles outlined.

: Not Applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below